GRTS - Gritstone Oncology - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

128.3M

Cash

46.3M

Avg Qtr Burn

-28.78M

Short % of Float

8.08%

Insider Ownership

2.08%

Institutional Own.

43.62%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GRANITE Details Gastric cancer, Colorectal cancer , Solid tumor/s, Cancer	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
samRNA Details COVID-19, Infectious disease	Phase 2b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLATE Details Colorectal cancer , Lung cancer, Solid tumor/s, Cancer	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.